Driving forward a new era in the treatment of CKD

ProKidney is currently conducting multiple clinical trials for risparencel, an innovative cell therapy candidate, designed to stop or delay progression of moderate to severe Diabetic Kidney Disease.

If you are a physician interested in participating in our clinical trial program, our clinical team wants to hear from you.